Lausanne, Switzerland – July 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Héritas SA, an Argentinian precision-medicine company. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Héritas’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.
New York and Lausanne, Switzerland - January 10, 2019 - Saphetor SA, the creator of VarSome, announced today a partnership with the Englander Institute for Precision Medicine at Weill Cornell Medicine, the creator of Precision Medicine Knowledgebase (PMKB), a curated resource for the clinical interpretation of cancer variants . PMKB is now a fundamental component of VarSome’s portfolio of over 30 integrated and cross-referenced public data resources as well as VarSome’s implementation of the American College of Medical Genetics guidelines.
We have recently published an article titled VarSome: The Human Genomic Variant Search Engine in Bioinformatics journal of Oxford Academic, so if you use VarSome for your work please cite it in your articles and all other communications.
Lausanne, Switzerland - November 26, 2018 - Saphetor SA, a Swiss precision medicine company and a leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing, announced today that Dr. Erik Zmuda has become a member of its Advisory Board.